格隆汇6月30日丨中国同辐(01763.HK)发布公告,近日,在第15届国际同位素标记化合物合成与应用研讨会上,中国同辐与秦山核电站联合研发的C-14碳酸钡产品惊艳亮相,并与英国、瑞士、德国等国家的行业领军企业达成多项销售合作备忘录及销售协议,是我国堆产医用同位素首次实现批量化出口。作为放射性标记技术的核心原料,C-14碳酸钡广泛应用于药代动力学研究、幽门螺杆菌检测(尿素呼气试验)、农药代谢分析等...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.